Taxonomic position and features
The causative agent of pneumocystosis, Pneumocystis jirovecii (previously known as Pneumocystis jiroveci), is classified as an opportunistic yeast-like fungus. However, this microorganism exhibits a unique duality: in its morphology and resistance to classical antifungal drugs (antimycotics), it demonstrates typical properties of protozoa.
Morphology and life cycle
The life cycle of the pathogen takes place exclusively in the lung alveoli, where the microorganisms are located within a foamy exudate. They have a marked tropism for type II pneumocytes. Development includes four consecutive stages:
- Trophozoite.
This is an extracellular parasite measuring 1.5–5 µm, oval or amoeboid in shape. Externally, it is covered with a capsule and pellicle. Trophozoites form clusters that closely adhere to the alveolar epithelium. Using special pellicle outgrowths, they invade type I pneumocytes.
- Precyst.
At this stage, the trophozoite rounds up, and its cell wall thickens significantly.
- Cyst.
The mature form measuring 4–8 µm. It has a thick three-layered cell wall rich in polysaccharides (due to which it stains intensely). Inside the cyst, a characteristic structure forms—a "rosette" consisting of 8 daughter cells.
- Intracystic bodies (sporozoites).
Small structures measuring 1–2 µm, equipped with a small nucleus and a two-layered membrane.
The cycle closes when the cyst ruptures: the intracystic bodies are released and transform into new extracellular trophozoites.
Epidemiology
Pneumocystosis is a strict anthroponosis. This means that the source of infection can only be a human (a patient or healthy carrier); zoonotic transmission is excluded.
- Transmission mechanism: aerogenic (predominantly airborne droplet route).
- Prevalence: the pathogen circulates extremely widely. Primary infection in most people occurs in early childhood (usually by 3–4 years of age). As a result, over 70% of the healthy adult population has specific antibodies against Pneumocystis.
In individuals with normal immune function, the infection proceeds as asymptomatic carriage.
Clinical presentation
Pneumocystis pneumonia is a typical opportunistic infection that manifests only against the background of suppressed immunity. The incubation period lasts from 1 to 5 weeks.
The classical symptom complex includes:
- Fever.
- Pronounced dyspnea.
- Dry cough.
The disease is characterized by high mortality. If the patient is not prescribed specific treatment, there is a high risk of a fatal outcome due to progressive respiratory failure.
Microbiological diagnostics
The main method for detecting Pneumocystis jirovecii is microscopy. Sputum, lung tissue biopsy, or bronchoalveolar lavage (BAL) fluid is used for the study.
Several staining methods are used to visualize the pathogen:
- Romanowsky–Giemsa stain. Allows assessment of internal structure. The cytoplasm of the microorganism stains blue, and the nucleus acquires a reddish-purple hue.
- Special methods. Aimed at detecting the polysaccharide-rich cell wall of the cysts. These include toluidine blue staining and Gomori methenamine silver (GMS) staining.
Briefly: answers to topical questions
What laboratory diagnostic methods, besides microscopy, are used to confirm pneumocystosis?
To confirm pneumocystosis, in addition to microscopy, molecular biological methods are used, including polymerase chain reaction (PCR) to detect and quantify Pneumocystis jirovecii DNA in bronchoalveolar lavage, sputum, and endotracheal aspirate. When diagnosing lung damage caused by pneumocystis, bronchoalveolar lavage analysis is performed using enzyme-linked immunosorbent assay (ELISA) and PCR.
Pneumocystis is like a "wolf in sheep's clothing": biologically it is a fungus, but it behaves and defends itself (against antimycotics) like a protozoan. It hides in the foamy exudate of the alveoli.
Class and exam questions
Why is pneumocystosis called an opportunistic infection?
Because in people with normal immunity, the pathogen causes only asymptomatic carriage. The disease (pneumonia) develops only with a severe decrease in the body's defenses, for example, in AIDS.
What is the paradox of the taxonomy of Pneumocystis jirovecii?
The microorganism genetically belongs to fungi, but classical antifungal drugs do not affect it, and morphologically it shares many features with protozoa.
What is a mature pneumocystis cyst?
This is a structure measuring 4–8 µm with a thick polysaccharide cell wall, inside which there is a "rosette" of 8 intracystic bodies (sporozoites).
Which staining method best highlights the cyst wall?
Gomori methenamine silver (GMS) staining or toluidine blue staining is used to stain the polysaccharide wall of the cysts.
What else to study on this topic
- Interaction of trophozoite pellicle outgrowths with type I pneumocytes
- Features of the chemical composition of the pneumocystis cell wall
- Differential diagnosis of pneumocystosis in HIV-infected patients
- Mechanisms of foamy exudate formation in the alveoli
- Pathogenesis of respiratory failure in Pneumocystis pneumonia
Study the full topic in the «Microbiology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Pneumocystosis (Pneumocystis jirovecii)" and 4,383 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 141 video lectures on the subject
Other topics in the section "Opportunistic mycoses (candidiasis, aspergillosis, pneumocystosis, etc.)"
Free video lessons: microbiologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.